Now position:HomeGLOBAL FOOTPRINTLaunch Plan

GLOBAL FOOTPRINT

GLOBAL FOOTPRINT

Launch Plan

REBLOOD Biotech Corp. business operations are based out of Taiwan. However, it is registered in Nevada, USA and is established as a wholly owned subsidiary in Hong Kong. REBLOOD Biotech Limited is in charge of Asian operations and has plans to establish an Indo-Pacific Regenerative Medicine Center in Thailand.

Our company has signed with Leader Capital Asset Management Limited (Cayman) in April of 2020 to advise us on our OTC Markets listing plan.